Skip to main content

Table 2 Echocardiographic results and follow up (*1 patient with an event 10 days after CV was excluded due to discontinuation of anticoagulation; abbreviations see text)

From: Contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce associated thromboembolic events

  Contrast-enhanced TEE Control group p value
n 90 90  
thrombus detected (%) 10 (11.1) 10 (11.1)  
LAA-flow (m/s) 0.32 ±0.2 0.29 ±0.2 0.75
LAA-flow ≤ 0.3m/s (%) 7 (70) 8 (80) 0.606
SEC (no/minor-moderate/ marked) 2 / 6 / 2 0 / 4 / 6 0.111
LA diameter (mm) 47.6±7.2 50.1±6.1 0.429
thrombus excluded / unclear 80 (88.9) 80 (88.9)  
LAA-flow (m/s) 0.47 ±0.2 0.48 ±0.2 0.711
SEC (no/minor-moderate/ marked) 35 / 38 / 7 25 / 48 / 7 0.243
LA diameter (mm) 46.5±6.3 46.6±7.3 0.895
CV performed (%) 74 (82.2) 76 (84.4) 0.514
CV related events (%) 0 (0)* 3 (3.9) 0.084